期刊文献+

缬沙坦胶囊对老年高血压患者血管内皮功能的影响 被引量:2

Influence of valsarta capsule on the function of the vascular endothelium in elderly patients with hypertension
下载PDF
导出
摘要 目的 探讨缬沙坦(valsarta)对血管内皮功能的影响以及对老年高血压(EH)的疗效.方法 64例EH患者(EH组),给予缬沙坦治疗4周,剂量80~160 mg/d,60例健康老年人作为对照组,测量2组治疗前后血压及血浆一氧化氮(nitric oxide,NO)和内皮素(endothelin,ET-1)水平。结果 治疗前,EH组血浆NO浓度显著低于对照组(P<0.01),而血浆ET-1浓度明显高于对照组(P<0.01);EH组血压变化与血浆NO浓度呈负相关而与ET-1浓度呈正相关.经缬沙坦治疗4周后,收缩压及舒张压均明显下降(P<0.01),但心率变化不显著(P>0.05),治疗总有效率为87.5%.治疗4周后血浆NO水平显著升高(P<0.05),且分级越高,血浆NO及ET-1浓度变化越显著。结论 缬沙坦有显著的降压疗效,可以显著修复和改善EH不良的血管内皮结构及功能. Objective To investigate the influence of valsarta capsule on the function of vascular endothelium in elderly patients with hypertension and its therapeutic effect on senile hypertension. Methods 64 elderly hypertension (EH) patients were treated with valsarta for 4 weeks with the dose range from 80 to 160 mg/d and then compared with 60 healthy elderly people before and after treatment by measuring the levels of blood pressure, plasma nitric oxide and endothelin (ET-1).Results The nitric oxide levels in EH group were significantly lower than those of control group ( P 〈 0.01), while the levels of ET-1 were obviously higher than those of control group ( P 〈 0.01). The change of blood pressure in EH group was negatively related with the levels of nitric oxide,however which was positively related with the levels of ET-1.After 4-week' treatment with valsarta, systolic and diastolic pressures in both groups remarkably decreased,as compared with those before treatment ( P 〈0.01) ,but their heart rates didn' t change significantly ( P 〉 0.06),and the total effective rate was 87.5%. The nitric oxide levels were increased significantly ( P 〈0.05) ,and the higher the degree was,the more notable the change of nitric oxide levels and ET-1 levels became. Conclusion Valsarta is effective in treating hypertension, which may improve poor structure and function of vascular endothelium.
出处 《河北医药》 CAS 2006年第6期449-450,共2页 Hebei Medical Journal
关键词 缬沙坦 高血压 一氧化氮 内皮素 valsarta hypertension nitric oxide endothelin
  • 相关文献

参考文献6

二级参考文献20

  • 1Pitt B,Segal R.Martinez FA,et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).Lancet, 1997,349:747-752.
  • 2Pitt B,Poole-Wilson PA,Segal R,et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.Lancet, 2000,355:1582-1587.
  • 3Daholof B,Devereux RB,Kjeldsen SE,et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.Lancet,2002,359:995-1003.
  • 4Lewis EJ,Hunsicker LG,Clarke WR,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.N Engl J Med, 2001,345:851-860.
  • 5Circulation, 2002;106:672.
  • 6Parving HH,Lehnert H,Brochner-Mortensen J,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.N Engl J Med, 2001,345:870-878.
  • 7Brenner BM,Cooper ME,de Zeeuw D,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.N Engl J Med. 2001 Sep 20;345(12):861-869.
  • 8Lithell H,Hansson L,Skoog I,et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.J Hypertens, 2003,21:875-886.
  • 9ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Groop. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lo
  • 10Wong M,Staszewsky L,Latini R,et al. Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study.J Am Coll Cardiol, 2002,40:970-975.

共引文献105

同被引文献21

  • 1郭慧峰,李燕,王谷亮,陆勇刚,周怀发,高平进,朱鼎良,王继光.浙江景宁人群中α-内收蛋白基因Gly460Trp多态性与外周及中心动脉血压的关系[J].中华心血管病杂志,2005,33(7):608-612. 被引量:10
  • 2蔡俊明,邓健忠,陈先辉.社区干预对高血压患者卫生行为和疗效的作用[J].中国全科医学,2005,8(16):1343-1344. 被引量:10
  • 3Cheidin MD, Alpert JS, Armstrong WF, et al. ACC/AHA Guideline for the clinical application of echecardiography : Executive summary. A report of American College of Cardiology/American Hart Association Task Force on practice guideline ( Committee on Clinical Application of Echocardiography) [J]. J Am Coil Cardiol, 1997, 29:862 -879.
  • 4Remington JW, Hamilton WF, Gold JJ, et al. Volume elasticity characteristics of human aorta and prediction of stroke volume from pressure pulse [J]. Am JPhysiol, 1948, 153: 298-308.
  • 5London GM, Guerin AP, Dannier B, et al. Large artery structure and function in hypertension and renal disease [J]. Hypertens, 16:1931 - 1938.
  • 6Stanton AV, Chapman JN, Mayet J, et al. Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common coritid artery [J]. Clin Sci, 2001, 101 : 455 -464.
  • 7Simone G, Roman MJ, Koren Mj, et al. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension [ J ]. Hypertension, 1999, 33: 800-805.
  • 8Myers MG. Recent advances in automated blood pressure measurement [ J ]. Curr Hypertens Rep,2008 ; 10 (5) :355-8.
  • 9杨光,玄春花.瑞舒伐他汀对老年高血压患者血压及血清C-反应蛋白水平的影响[J].中国心血管病研究,2010,8(2):118-119. 被引量:6
  • 10金善律,张铁辉,刘海波.辛伐他汀对老年高血压患者血管内皮功能的影响[J].中国急救复苏与灾害医学杂志,2010(3):252-253. 被引量:2

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部